Tempest Therapeutics, Inc. is a biopharmaceutical company based in Brisbane, CA, specializing in the development of innovative targeted and immune-mediated cancer therapies. Their pipeline consists of first-in-class small molecule product candidates that have the potential to provide broad benefits to patients.
With a focus on modulating validated and new pathways, Tempest Therapeutics aims to develop novel therapeutics that can effectively combat cancer. They have been actively involved in scientific research and have made significant progress in their mission to bring groundbreaking treatments to the market.
Generated from the website